SEO URLwww.firestrike.ai/deals/radius-b-flexion-life-sciences-acquisition-2026-1
acquisitionAnnounced · Jan 14, 2026biopharmaceuticalSource · CredibleArticle · Factual
B-Flexion Life Sciences acquires Radius
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
—
Target
Radius
NASDAQ:RDUS · Boston, Massachusetts
Acquirer
B-Flexion Life Sciences
Full Acquisition
Status
Pending
B-Flexion Life Sciences agreed to acquire Radius. Reported deal value: Undisclosed. Status: Pending. Sector: biopharmaceutical. Target headquarters context: Boston, Massachusetts, United States.
This page summarizes publicly available information about the transaction as of 2026-01-14. Figures and status may change as filings and press coverage update.
B‑ Flexion Life Sciences has agreed to purchase the shares in US-based bone health specialist Radius Health, Inc. that are currently held by affiliates of Patient Square Capital and Webster Equity Partners
Deal timeline
Announced
Jan 14, 2026 · investorsinhealthcare.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in biopharmaceutical. Figures and status may change as sources update.
Sources: investorsinhealthcare.com · Primary article · FireStrike proprietary index